1. Home
  2. SVCO vs LRMR Comparison

SVCO vs LRMR Comparison

Compare SVCO & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • LRMR
  • Stock Information
  • Founded
  • SVCO 1984
  • LRMR N/A
  • Country
  • SVCO United States
  • LRMR United States
  • Employees
  • SVCO N/A
  • LRMR N/A
  • Industry
  • SVCO
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVCO
  • LRMR Health Care
  • Exchange
  • SVCO NYSE
  • LRMR Nasdaq
  • Market Cap
  • SVCO 221.9M
  • LRMR 183.8M
  • IPO Year
  • SVCO 2024
  • LRMR N/A
  • Fundamental
  • Price
  • SVCO $4.63
  • LRMR $2.00
  • Analyst Decision
  • SVCO Strong Buy
  • LRMR Strong Buy
  • Analyst Count
  • SVCO 6
  • LRMR 10
  • Target Price
  • SVCO $20.50
  • LRMR $19.60
  • AVG Volume (30 Days)
  • SVCO 184.5K
  • LRMR 906.5K
  • Earning Date
  • SVCO 03-05-2025
  • LRMR 05-08-2025
  • Dividend Yield
  • SVCO N/A
  • LRMR N/A
  • EPS Growth
  • SVCO N/A
  • LRMR N/A
  • EPS
  • SVCO N/A
  • LRMR N/A
  • Revenue
  • SVCO $59,680,000.00
  • LRMR N/A
  • Revenue This Year
  • SVCO $19.13
  • LRMR N/A
  • Revenue Next Year
  • SVCO $20.27
  • LRMR N/A
  • P/E Ratio
  • SVCO N/A
  • LRMR N/A
  • Revenue Growth
  • SVCO 10.02
  • LRMR N/A
  • 52 Week Low
  • SVCO $4.46
  • LRMR $1.96
  • 52 Week High
  • SVCO $21.59
  • LRMR $11.20
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • LRMR 29.98
  • Support Level
  • SVCO N/A
  • LRMR $2.19
  • Resistance Level
  • SVCO N/A
  • LRMR $2.44
  • Average True Range (ATR)
  • SVCO 0.00
  • LRMR 0.18
  • MACD
  • SVCO 0.00
  • LRMR -0.01
  • Stochastic Oscillator
  • SVCO 0.00
  • LRMR 4.81

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: